SenGenix company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

sengenix.com

Founded Year

2012

Stage

Unattributed | Alive

Total Raised

$10.79M

Last Raised

$6.27M | 5 yrs ago

About SenGenix

SenGenix is developing point-of-care diagnostic tests (POCT) based on fluorescently responsive sensors (FRS) that will deliver fast, accurate, actionable patient data at a low cost. The Company will commercialize protein-engineering technologies developed at Duke University Medical Center to create a product platform that will be designed to perform a menu of tests at the point-of-care. The product roll-out strategy over the next five years includes a stand-alone Creatinine test, and a Basic Metabolic Panel (BMP) consisting of the eight most commonly ordered tests (Glucose, BUN, Creatinine, Sodium, Potassium, Calcium, Chloride and Bicarbonate). These will provide clinicians with highly accurate results to assess patients at the location where care is required and within a time frame during which clinical decisions are most effective.

SenGenix Headquarter Location

1738 Hillandale Road Suite 102

Durham, North Carolina, 27705,

United States

919-864-8693

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing SenGenix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SenGenix is included in 4 Expert Collections, including Medical Devices.

M

Medical Devices

7,913 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

3,095 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health

12,795 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

7,900 items

Latest SenGenix News

Coagulation Testing Market Strategies of Key Players: CoaguSense, Inc., HemoSonics, LLC, iLine Microsystems., Instrumentation Laboratory Company, Sienco, Inc., SenGenix., Bio/Data Corporation

Jul 16, 2020

Search jobs 15-Jul-2020 Coagulation Testing Market Strategies of Key Players: CoaguSense, Inc., HemoSonics, LLC, iLine Microsystems., Instrumentation Laboratory Company, Sienco, Inc., SenGenix., Bio/Data Corporation This Coagulation Testing Market report has been formulated by considering an ever increasing demand and the value of market research for the success of different business sectors. This market report comprises of many work areas of the Medical Devices industry. It is not only professional but also is a comprehensive which focuses on primary and secondary drivers, market share, competitor analysis, leading segments and geographical analysis. Moreover, this report is prepared with the combination of greatest industry insight, practical solutions, talent solutions and most recent technology. The Coagulation Testing Market advertising report also considers the major driving factors of the industry and the market restraints which generally causes inhibition. For In-Depth Information Get Sample Copy of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-coagulation-testing-market Global coagulation testing market is expected to rise by 2026, registering a substantial CAGR of 7.95% in the forecast period of 2019-2026. Rising demand of special coagulation testing and increasing chronic diseases among consumer is the major factor for the growth of this market. Few of the major competitors currently working in the global coagulation testing market are: F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthcare Private Limited, CoaguSense, Inc., HemoSonics, LLC, iLine Microsystems., Instrumentation Laboratory Company, Sienco, Inc., SenGenix., Bio/Data Corporation, Universal Biosensors, RUSNANO Group, Coagulation Sciences LLC, Tcoag Ireland, SEKISUI MEDICAL CO., LTD, Thermo Fisher Scientific, Inc., Machaon Diagnostics, Inc., Laboratory Corporation of America Holdings, A&T Corporation., Sysmex, Universal Biosensors and others. Segmentation: Coagulation Testing Market View Detailed Table of Content @  https://www.databridgemarketresearch.com/toc/?dbmr=global-coagulation-testing-market Key Developments in the Market: In June 2018, Roche announced the launch of their new self-testing device for INR or blood coagulation levels namely CoaguChek Vantus. This is specially designed for the Warfarin patients so that they can monitor their coagulation levels. This will increase the connectivity between the patients and healthcare provider and will provide easy and high quality testing In May 2017, Stago group announced that they have acquired HemoSonics LLC. This acquisition will help the company to develop new Point-of-Care in Haemostasis testing and beyond with the assistance of the SEER technology (Sonic Estimation of Elasticity via Resonance) and QuantraTM Hemostasis Analyzer. The main aim of the acquisition is to provide better treatment to the patients Competitive Analysis: Global coagulation testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of coagulation testing market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa. Reasons to Purchase this Report Current and future of global coagulation testing market outlook in the developed and emerging markets The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period Regions/Countries that are expected to witness the fastest growth rates during the forecast period The latest developments, market shares, and strategies that are employed by the major market players Customization of the Report: All segmentation provided above in this report is represented at country level All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization) Coagulation Testing Market Drivers Rising awareness about the preservative care management is another factor driving the market growth. Technological advancement and development in coagulation testing devices is major factor driving market Increasing prevalence for disposable coagulation testing devices is driving the market Coagulation Testing Market Restraints Lack of skilled and trained professional is another factor restraining the market growth Strict regulation related to coagulation device is another factor restraining the growth of this market View Full Report @ https://www.databridgemarketresearch.com/reports/global-coagulation-testing-market An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. Contact:

  • When was SenGenix founded?

    SenGenix was founded in 2012.

  • Where is SenGenix's headquarters?

    SenGenix's headquarters is located at 1738 Hillandale Road, Durham.

  • What is SenGenix's latest funding round?

    SenGenix's latest funding round is Unattributed.

  • How much did SenGenix raise?

    SenGenix raised a total of $10.79M.

  • Who are the investors of SenGenix?

    Investors of SenGenix include Duke University.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.